BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16177825)

  • 1. Crystal structure of the C3bot-RalA complex reveals a novel type of action of a bacterial exoenzyme.
    Pautsch A; Vogelsgesang M; Tränkle J; Herrmann C; Aktories K
    EMBO J; 2005 Oct; 24(20):3670-80. PubMed ID: 16177825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase.
    Holbourn KP; Sutton JM; Evans HR; Shone CC; Acharya KR
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5357-62. PubMed ID: 15809419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the Rho-ADP-ribosylating C3 exoenzyme with RalA.
    Wilde C; Barth H; Sehr P; Han L; Schmidt M; Just I; Aktories K
    J Biol Chem; 2002 Apr; 277(17):14771-6. PubMed ID: 11847234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the Clostridium limosum C3 exoenzyme.
    Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
    FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.
    Vogelsgesang M; Pautsch A; Aktories K
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):347-60. PubMed ID: 17146673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
    Vogelsgesang M; Aktories K
    Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure.
    Toda A; Tsurumura T; Yoshida T; Tsumori Y; Tsuge H
    J Biol Chem; 2015 Aug; 290(32):19423-32. PubMed ID: 26067270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational plasticity is crucial for C3-RhoA complex formation by ARTT-loop.
    Tsuge H; Yoshida T; Tsurumura T
    Pathog Dis; 2015 Dec; 73(9):ftv094. PubMed ID: 26474844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure.
    Evans HR; Holloway DE; Sutton JM; Ayriss J; Shone CC; Acharya KR
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1502-5. PubMed ID: 15272191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the active-site structure of C3-like exoenzymes: involvement of glutamic acid in catalysis of ADP-ribosylation.
    Aktories K; Jung M; Böhmer J; Fritz G; Vandekerckhove J; Just I
    Biochimie; 1995; 77(5):326-32. PubMed ID: 8527485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes.
    Ménétrey J; Flatau G; Boquet P; Ménez A; Stura EA
    Protein Sci; 2008 May; 17(5):878-86. PubMed ID: 18369192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174Q.
    Rohrbeck A; Kolbe T; Hagemann S; Genth H; Just I
    FEBS J; 2012 Aug; 279(15):2657-71. PubMed ID: 22621765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-ADP-ribosylating exoenzyme from Bacillus cereus. Purification, characterization, and identification of the NAD-binding site.
    Just I; Selzer J; Jung M; van Damme J; Vandekerckhove J; Aktories K
    Biochemistry; 1995 Jan; 34(1):334-40. PubMed ID: 7819216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum.
    Just I; Mohr C; Schallehn G; Menard L; Didsbury JR; Vandekerckhove J; van Damme J; Aktories K
    J Biol Chem; 1992 May; 267(15):10274-80. PubMed ID: 1587816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural constraints-based evaluation of immunogenic avirulent toxins from Clostridium botulinum C2 and C3 toxins as subunit vaccines.
    Prisilla A; Prathiviraj R; Sasikala R; Chellapandi P
    Infect Genet Evol; 2016 Oct; 44():17-27. PubMed ID: 27320793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD binding induces conformational changes in Rho ADP-ribosylating clostridium botulinum C3 exoenzyme.
    Ménétrey J; Flatau G; Stura EA; Charbonnier JB; Gas F; Teulon JM; Le Du MH; Boquet P; Menez A
    J Biol Chem; 2002 Aug; 277(34):30950-7. PubMed ID: 12029083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-ribosylation of the rho/rac gene products by botulinum ADP-ribosyltransferase: identity of the enzyme and effects on protein and cell functions.
    Narumiya S; Morii N; Sekine A; Kozaki S
    J Physiol (Paris); 1990; 84(4):267-72. PubMed ID: 2127805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-modifying C3-like ADP-ribosyltransferases.
    Aktories K; Wilde C; Vogelsgesang M
    Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Glu173 as the critical amino acid residue for the ADP-ribosyltransferase activity of Clostridium botulinum C3 exoenzyme.
    Saito Y; Nemoto Y; Ishizaki T; Watanabe N; Morii N; Narumiya S
    FEBS Lett; 1995 Sep; 371(2):105-9. PubMed ID: 7672106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.